Author response for "Pharmacokinetics, Pharmacodynamics, and Tolerability of Single‐ and Multiple‐Doses of Janagliflozin, a Sodium–Glucose Cotransporter 2 Inhibitor, in Chinese Subjects with Type 2 Diabetes Mellitus"
2020 ◽
2020 ◽
2020 ◽
2020 ◽
2020 ◽
2020 ◽
2020 ◽
2020 ◽
2020 ◽
2020 ◽